mbs303MBS-303: CD20CD3Beijing Mabworks Biotech Co., Ltd. ()12MBS303MSC303 (MBS303 as the intravenous formulation, MSC303 as the subcutaneous formulation) is an innovative CD20CD3 T-cell engager. MBS303 has initiated clinical trials